Codes / ICD10CM / T36.3X4A

T36.3X4A Poisoning by macrolides, undetermined, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by macrolides, undetermined, initial encounter

Summary

This condition describes poisoning from macrolide antibiotics where the intent (accidental, intentional, or therapeutic error) is not specified, and it is the initial encounter for care. Documentation should clarify the type of macrolide involved, clinical findings, and the circumstances of exposure to support the diagnosis.

Causes

Poisoning may result from accidental or intentional exposure to macrolides, though the intent is undetermined. This can include overdose, incorrect administration, or unintended ingestion. Adverse effects may arise from idiosyncratic reactions, drug interactions, or cumulative toxicity, even at therapeutic doses.

Risk Factors

  • Prior history of macrolide allergies or sensitivities.
  • Polypharmacy increasing interaction risks.
  • Renal or hepatic impairment affecting drug metabolism.
  • Pediatric or geriatric populations with altered pharmacokinetics.
  • Inadequate patient education on medication use.

Symptoms

  • Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
  • Allergic: Rash, urticaria, anaphylaxis.
  • Systemic: Fever, hypotension, organ dysfunction (e.g., hepatotoxicity).
  • Neurological: Dizziness, confusion, or altered mental status.

Diagnosis

Diagnosis is based on clinical presentation, patient history of macrolide exposure, and laboratory findings (e.g., drug levels, toxicology screens). Corroborating evidence, such as witness accounts or medication records, may help clarify the circumstances of exposure when intent is unclear.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further absorption (e.g., activated charcoal). Supportive care, such as IV fluids or antiemetics, may be used. Specific antidotes are not available for macrolide poisoning, so management is symptomatic.

Prognosis and Follow-Up

Prognosis depends on the dose, type of macrolide, and timely intervention. Most cases resolve with supportive care, but severe toxicity can lead to organ damage. Follow-up includes monitoring for delayed reactions and assessing for underlying causes of exposure.

Complications

  • Gastrointestinal: Severe dehydration or electrolyte imbalances.
  • Allergic: Anaphylaxis or chronic hypersensitivity.
  • Systemic: Hepatotoxicity, nephrotoxicity, or cardiovascular instability.
  • Neurological: Prolonged confusion or seizures.

Lifestyle & Prevention

  • Store medications securely to prevent accidental ingestion.
  • Educate patients on proper dosing and potential side effects.
  • Review medication lists regularly to avoid interactions.
  • Supervise pediatric or cognitively impaired individuals during medication use.

When to Seek Professional Help

Seek immediate care for symptoms like difficulty breathing, severe abdominal pain, or altered mental status. Contact a healthcare provider if exposure is suspected, even without obvious symptoms.

Tips for Medical Coders

Document the type of macrolide, clinical details of exposure, and the reason for undetermined intent (e.g., lack of history). Ensure the encounter is classified as "initial" if it is the first presentation for this poisoning. Include any relevant lab results or corroborating evidence to support the diagnosis.

Book a walkthrough

T36.3X4A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.